Efficacy and safety of crizotinib in previously treated patients (pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y) Meeting Abstract
| Authors: | Moro-Sibilot, D.; Ahn, M. J.; Halmos, B.; Kim, D. W.; Riely, G. J.; Shaw, A. T.; Yang, P. C.; Lanzalone, S.; Polli, A.; Wilner, K. D.; De Castro Carpeño, J. |
| Abstract Title: | Efficacy and safety of crizotinib in previously treated patients (pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy292.019 |
| Language: | English |
| ACCESSION: | WOS:000459277303167 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy292.019 |
| Notes: | Meeting Abstract: 1396P -- Appears on page viii503 of the abstract book -- Source: Wos |
